logo

CME Group files S-4 form with SEC relating to Nymex deal


CME Group has filed S-4 form with the US Securities and Exchange Commission (SEC) the exchange’s...

The rest of this article is for subscribers only. Would you like to take a free trial?

Free trial

  • News & Analysis access
  • Extensive data searches
  • Access to archive
  • Weekly newsletter